Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleRed Hat
CEO ReviewCompany Review

The Silicon Review Asia

China approves Genuine Biotech's HIV drug, Azvudine for COVID patients

China approves Genuine Biotech's HIV drug, Azvudine for COVID patients

In a clinical trial, 40.4 percent of patients given Azvudine showed improvement

China has given conditional approval to domestic firm Genuine Biotech's Azvudine pill, which is proven effective in treating certain adult patients with COVID-19. Thus, adding another oral treatment option against the coronavirus. The availability of effective COVID-19 treatments and vaccines is crucial in laying the foundation for China's potential shift from its "dynamic COVID zero" policy, which aims to eliminate every outbreak and relies on strict quarantining and mass testing. The Azvudine tablet, which China approved last year to treat certain HIV-1 virus infections, has been given a conditional green light to treat adult patients with "normal type" COVID-19, the National Medical Products Administration said in a statement. “Normal type" COVID-19 is a term China uses to refer to coronavirus infections where there are signs of pneumonia, but the patients haven't reached a severe stage.

In a late-stage clinical trial, 40.4 percent of patients who were administered Azvudine showed improvement in symptoms seven days after first taking the drug, compared with 10.9 percent in the control group, Henan province-based Genuine Biotech said in a statement earlier this month, without providing detailed readings. Other Chinese companies developing potential oral COVID-19 treatments include Shanghai Junshi Biosciences and Kintor Pharmaceutical.


Pine Labs Reaffirms its Commitment to Indian Payments Space with Qfix Acquisition

HDFC Bank is Qfix's main distribution partner Pine Labs has announced that it has acquired Qfix, a Mumbai-based online payments startup. This acquisi...

Salesforce Expands into Thailand, Opens Office in Bangkok

Salesforce has announced permanent presence in Thailand by launching its new office in the country’s capital, Bangkok. The permanent presence wi...

GMLL is expected to soon add two more stores to its retail arm ‘Price Mantra’

Garment Mantra Lifestyle, a popular name in the Indian fashion retail segment, recently made an announcement that the company is expanding its retail ...

Tariff plans will cost higher from the next financial year as telecom companies are gearing up to increase rates

The ongoing Covid pandemic had significantly increased the number of mobile and internet users worldwide. The high amount of usage is expected to drop...